Related Experiment Video
Updated: Jul 3, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Antifungal prophylaxis in neutropenic patients
1University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.
Abstract:
Although a number of studies have been published on antifungal prophylaxis in neutropenic and bone marrow transplantation patients, there are a lot of conflicting data. Some of this may be due to a lack of consensus on the definition of fungal disease and the definition of end-points for treatment. The risk factors associated with fungal infection, the causative species and the antifungals currently used for prophylaxis are reviewed. Future trends in prophylaxis, such as the use of growth factors and peripheral blood stem cells are discussed.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Antiprotozoal Agents
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Fungal Phylum Microsporidia
